SCHEMBL22097264

SCHEMBL22097264

c1ccc(-c2cc(-c3ccccc3)nc(-c3ccc4c(c3)c3ccccc3c3cc5c(cc43)sc3ccccc35)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.43
KMT2A Q03164 11/20 0.43
ALDH1A1 P00352 9/20 0.43
HPGD P15428 9/20 0.43
MAPT P10636 8/20 0.43
NTSR1 P30989 1/20 0.43
KDM4E B2RXH2 5/20 0.41
LMNA P02545 2/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
RAB9A P51151 1/20 0.41
GPR3 P46089 1/20 0.39
GLA P06280 1/20 0.38
TSHR P16473 2/20 0.37
ATM Q13315 2/20 0.37
ADORA2A P29274 2/20 0.37
ADORA1 P30542 2/20 0.37
USP2 O75604 1/20 0.37
MAPK1 P28482 1/20 0.37
HTT P42858 1/20 0.37
HSD17B10 Q99714 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22097088 0.96 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22096974 0.96 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22097269 0.95 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22097287 0.95 MEN1 (0.44) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18960975 0.93 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL15964253 0.92 MEN1 (0.43) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL29747023 0.92 MAPT (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL22097214 0.92 MAPT (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL18371746 0.92 MAPT (0.42) MEN1KMT2AALDH1A1HPGDMAPT
SCHEMBL14644646 0.91 KDM4E (0.38) MEN1KMT2AALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2020-06-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200190065-A1 ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, OR10J3, PIEZO1 MEN1 1207/4885KMT2A 2500/4885ALDH1A1 1010/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.